These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
656 related articles for article (PubMed ID: 32265898)
1. Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis. Bertolo M; Baumgart S; Durek P; Peddinghaus A; Mei H; Rose T; Enghard P; Grützkau A Front Immunol; 2020; 11():256. PubMed ID: 32265898 [TBL] [Abstract][Full Text] [Related]
2. Urinary T cells in active lupus nephritis show an effector memory phenotype. Dolff S; Abdulahad WH; van Dijk MC; Limburg PC; Kallenberg CG; Bijl M Ann Rheum Dis; 2010 Nov; 69(11):2034-41. PubMed ID: 20472588 [TBL] [Abstract][Full Text] [Related]
3. Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages. Zhang T; Li H; Vanarsa K; Gidley G; Mok CC; Petri M; Saxena R; Mohan C Front Immunol; 2020; 11():671. PubMed ID: 32351512 [TBL] [Abstract][Full Text] [Related]
4. The cellular signature of urinary immune cells in Lupus nephritis: new insights into potential biomarkers. Kopetschke K; Klocke J; Grießbach AS; Humrich JY; Biesen R; Dragun D; Burmester GR; Enghard P; Riemekasten G Arthritis Res Ther; 2015 Apr; 17(1):94. PubMed ID: 25890061 [TBL] [Abstract][Full Text] [Related]
7. Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations. Abdulahad DA; Westra J; Bijzet J; Dolff S; van Dijk MC; Limburg PC; Kallenberg CG; Bijl M Arthritis Res Ther; 2012 Aug; 14(4):R184. PubMed ID: 22892043 [TBL] [Abstract][Full Text] [Related]
8. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis. Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570 [TBL] [Abstract][Full Text] [Related]
9. Cluster of differentiation-44 as a novel biomarker of lupus nephritis and its role in kidney inflammation and fibrosis. Wong CCY; Gao LY; Xu Y; Chau MKM; Zhang D; Yap DYH; Ying SKY; Lee CK; Yung S; Chan TM Front Immunol; 2024; 15():1443153. PubMed ID: 39411720 [TBL] [Abstract][Full Text] [Related]
11. Discovery and Qualification of Candidate Urinary Biomarkers of Disease Activity in Lupus Nephritis. Anania VG; Yu K; Pingitore F; Li Q; Rose CM; Liu P; Sandoval W; Herman AE; Lill JR; Mathews WR J Proteome Res; 2019 Mar; 18(3):1264-1277. PubMed ID: 30525646 [TBL] [Abstract][Full Text] [Related]
12. Immune cells and type 1 IFN in urine of SLE patients correlate with immunopathology in the kidney. Scott E; Dooley MA; Vilen BJ; Clarke SH Clin Immunol; 2016 Jul; 168():16-24. PubMed ID: 27102764 [TBL] [Abstract][Full Text] [Related]
14. Clinical and histological significance of urinary CD11c Kim J; Lee JS; Go H; Lim JS; Oh JS; Kim YG; Lee CK; Yoo B; Hong S Arthritis Res Ther; 2020 Jul; 22(1):173. PubMed ID: 32680578 [TBL] [Abstract][Full Text] [Related]
15. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus. Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C Front Immunol; 2022; 13():885307. PubMed ID: 35720325 [TBL] [Abstract][Full Text] [Related]
16. Urinary CD4 T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment response. Enghard P; Rieder C; Kopetschke K; Klocke JR; Undeutsch R; Biesen R; Dragun D; Gollasch M; Schneider U; Aupperle K; Humrich JY; Hiepe F; Backhaus M; Radbruch AH; Burmester GR; Riemekasten G Ann Rheum Dis; 2014 Jan; 73(1):277-83. PubMed ID: 23475982 [TBL] [Abstract][Full Text] [Related]
17. Immune-Related Urine Biomarkers for the Diagnosis of Lupus Nephritis. Morell M; Pérez-Cózar F; Marañón C Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281193 [TBL] [Abstract][Full Text] [Related]
18. Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis: Single centre, cross-disciplinary experience. Duran E; Yıldırım T; Taghiyeva A; Bilgin E; Arıcı M; Sağlam EA; Özen S; Üner M; Erdem Y; Kalyoncu U; Ertenli AI Lupus; 2022 Aug; 31(9):1147-1156. PubMed ID: 35658643 [TBL] [Abstract][Full Text] [Related]
19. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis. Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762 [TBL] [Abstract][Full Text] [Related]